Revenue: The sum of all revenue fields included for a company's operating activities.
Coya Therapeutics, Inc. (COYA) had Revenue of $3.55M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
$3.55M |
$-14.88M |
|
-- |
|
$3.55M |
|
$20.80M |
|
$-17.25M |
|
$1.65M |
|
$-15.60M |
|
$-15.60M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-14.88M |
|
$-17.25M |
|
$-17.22M |
|
15.24M |
|
15.24M |
|
$-0.98 |
|
$-0.98 |
|
Balance Sheet Financials | |
$44.31M |
|
$0.04M |
|
$0.04M |
|
$44.35M |
|
$3.82M |
|
-- |
|
$0.95M |
|
$4.77M |
|
$39.58M |
|
$39.58M |
|
$39.58M |
|
16.71M |
|
Cash Flow Statement Financials | |
$-10.29M |
|
$-0.03M |
|
$16.03M |
|
$32.63M |
|
$38.34M |
|
$5.71M |
|
$2.66M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
11.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-485.35% |
|
-485.35% |
|
-484.58% |
|
-438.96% |
|
-418.70% |
|
$-10.31M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-37.60% |
|
-37.60% |
|
-33.56% |
|
-37.60% |
|
$2.37 |
|
$-0.68 |
|
$-0.68 |